The largest database of trusted experimental protocols

4 protocols using rhtnf α

1

Cytotoxicity and Inflammatory Profiling of HTIW

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HTIW under investigation are all in commercial production, but the manipulations were done specifically for this study by Morgan Advanced Materials (Bromborough, UK) and were provided to Heriot-Watt University in a coded form to allow in vitro experiments to be blinded. DQ12 quartz was donated by the Institute of Occupational Medicine (IOM) (Edinburgh, UK) (DQ12 was included in this study as a positive control for effects pertaining to crystalline silica); TiO2 was from Tioxide, UK; nanoparticle carbon black (NPCB) was obtained from Degussa (Printex 90). rhTNF-α was from Immunotools (Friesoythe, Germany); AlamarBlue reagent, Gibco™ Penicillin-Streptomycin, RPMI 1640, phenol red-free MEM were from Thermo Fisher (Paisley, UK); QCL-1000 Endpoint Chromogenic LAL Assay was from Lonza (Slough, UK); Proteome Profiler Cytokine Array Kit, Magnetic Luminex Screening Assay, and DuoSet ELISA kits were from R&D Systems (Abingdon, UK); 1-hydroxyl-2,2,6,6-tetramethyl-4-oxo-piperidine (Tempone-H) was from Enzo Life Sciences (Exeter, UK). All other substances used were obtained from Sigma-Aldrich (Poole, UK).
+ Open protocol
+ Expand
2

Characterization of Copper Oxide Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
CuO NPs were obtained from Intrinsiq Materials Ltd (Farnborough, UK) and were supplied by the Nanovalid consortium (http://www.nanovalid.eu/). Acetonitrile (ACN) for LC-MS was purchased from VWR (Radnor, PA, USA). High-purity water (H2O) was produced using a Milli-Q Integral three purification system from Merck Millipore (Darmstadt, Germany). Standard substances used for identification were obtained from Merck (amino acids). Staurosporine (STS) was purchased from Proteinkinase.de (Kassel, Germany), camptothecin (CPT) from Abcam (Cambridge, UK), and rhTNF-α from Immunotools (Friesoythe, Germany). SYBR Green Supermix was purchased from Bio-Rad (Munich, Germany), RevertAid HMinus M-MulV reverse transcriptase from Fermentas (St. Leon-Roth, Germany), TRIzol reagent from Invitrogen, IL-8 ELISA kits from PeproTech, while Celltiter-Blue® (CTB) Cell Viability Assay was purchased from Promega (Madison, WI, USA), foetal calf serum (FCS) from PAA (Pasching, Austria). All other substances used were obtained from Sigma-Aldrich (St. Louis, MO, USA).
+ Open protocol
+ Expand
3

Cytokine-Induced Chemokine Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
SKBR3 and HC1954 cells were treated with recombinant human rhIFN-ɣ (10 ng/ml, 300–02, Peprotech), rhTNF-α (10 ng/ml, 1134013, Immunotools), rhIFN-β-1a (1000 U/ml, Rebif, Merck) and their combinations for 24 h prior to supernatant collection and chemokine analysis by ELISA.
+ Open protocol
+ Expand
4

Generation of Activated Dendritic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The peripheral blood mononuclear cells (PBMCs) were isolated from 30 ml of HLA-A2+ healthy donor blood with written consent under Siriraj Institutional Review Board ethical approval (COA no. Si 580/2018) by density centrifugation at 800 × g for 20 min at RT in lymphocyte separating medium (Corning Life Sciences). The monocytes were isolated and incubated for 1 h at 37°C. The non-adherence cells were collected and cryopreserved in human AB serum (MilliporeSigma) containing 10% dimethyl sulfoxide until use. The monocytes were transduced with IRFP-SmartDC or MSLN-SmartDC at 75 multiplicity of infection (MOI) together with 10 µg/ml protamine sulfate in AIM-V medium (Invitrogen; Thermo Fisher Scientific, Inc.). On day 5 post-transduction, 1 µg/ml of recombinant human RPS3 (cat. no. NBP2-90977; Novus Biologicals, LLC) was added. Monocytes were cultured in 100 ng/ml of rhGM-CSF (cat. no. 11343125; ImmunoTools GmbH) and 50 ng/ml of rhIL-4 (cat. no. 11340045; ImmunoTools GmbH) for five days and treated with 100 ng/ml of rhIFN-γ (cat. no. 11343536; ImmunoTools GmbH) and rhTNF-α (cat. no. 11343015; ImmunoTools GmbH) for additional 48 h served as positive control or conventional DC (conv. DC). All DCs were harvested on day 7 to check the activated characters.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!